| Dr Arthur Joseph Debaise, MD | |
|
2501 N Orange Ave, Suite 411, Orlando, FL 32803-4644 | |
| (407) 478-0517 | |
| (407) 646-7370 |
| Full Name | Dr Arthur Joseph Debaise |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 37 Years |
| Location | 2501 N Orange Ave, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235276056 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME 57231 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Orlando Health | Orlando, FL | Hospital |
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
As 10,000 baby boomers reach 65 each day, the incidence of cancer is increasing, estimated to increase by 67% between 2010 and 2030, bringing attention to the nation's response to cancer care. Cancer is diagnosed at a higher rate, accounts for more survivors, and results in more deaths than in younger patients.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the National Institutes of Health ("NIH") has awarded Dr. Jacek Pinski, Associate Professor of Medicine at the Norris Comprehensive Cancer Center of the University of Southern California, a grant of about US$1.5 million over three years to conduct a Phase 1/2 study in refractory prostate cancer with the Company's doxorubicin LHRH receptor targeted conjugate compound, AEZS-108.
The morale of British midwives is at an all time low and 10,000 extra staff are needed, according to a leading healthcare expert.
In a study published in the January 18 issue of Cell, researchers from the University of North Carolina Lineberger Comprehensive Cancer Center have developed a new method to visualize aging and tumor growth in mice using a gene closely linked to these processes.
Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.
› Verified 7 days ago
| Entity Name | Arthur J Debaise Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104067032 PECOS PAC ID: 7719037951 Enrollment ID: O20090610000473 |
News Archive
As 10,000 baby boomers reach 65 each day, the incidence of cancer is increasing, estimated to increase by 67% between 2010 and 2030, bringing attention to the nation's response to cancer care. Cancer is diagnosed at a higher rate, accounts for more survivors, and results in more deaths than in younger patients.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the National Institutes of Health ("NIH") has awarded Dr. Jacek Pinski, Associate Professor of Medicine at the Norris Comprehensive Cancer Center of the University of Southern California, a grant of about US$1.5 million over three years to conduct a Phase 1/2 study in refractory prostate cancer with the Company's doxorubicin LHRH receptor targeted conjugate compound, AEZS-108.
The morale of British midwives is at an all time low and 10,000 extra staff are needed, according to a leading healthcare expert.
In a study published in the January 18 issue of Cell, researchers from the University of North Carolina Lineberger Comprehensive Cancer Center have developed a new method to visualize aging and tumor growth in mice using a gene closely linked to these processes.
Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arthur Joseph Debaise, MD 2501 N Orange Ave, Suite 411, Orlando, FL 32803-4644 Ph: (407) 478-0517 | Dr Arthur Joseph Debaise, MD 2501 N Orange Ave, Suite 411, Orlando, FL 32803-4644 Ph: (407) 478-0517 |
News Archive
As 10,000 baby boomers reach 65 each day, the incidence of cancer is increasing, estimated to increase by 67% between 2010 and 2030, bringing attention to the nation's response to cancer care. Cancer is diagnosed at a higher rate, accounts for more survivors, and results in more deaths than in younger patients.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the National Institutes of Health ("NIH") has awarded Dr. Jacek Pinski, Associate Professor of Medicine at the Norris Comprehensive Cancer Center of the University of Southern California, a grant of about US$1.5 million over three years to conduct a Phase 1/2 study in refractory prostate cancer with the Company's doxorubicin LHRH receptor targeted conjugate compound, AEZS-108.
The morale of British midwives is at an all time low and 10,000 extra staff are needed, according to a leading healthcare expert.
In a study published in the January 18 issue of Cell, researchers from the University of North Carolina Lineberger Comprehensive Cancer Center have developed a new method to visualize aging and tumor growth in mice using a gene closely linked to these processes.
Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.
› Verified 7 days ago
Dr. Christopher Dean Prevel, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5979 Vineland Rd, Suite 114, Orlando, FL 32819 Phone: 407-352-1818 Fax: 407-352-1814 | |
Dr. Kenrick Anthony Spence I, M.D., F.A.C.S. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 130 Hillcrest St, Orlando, FL 32801 Phone: 407-999-2585 Fax: 407-999-2628 | |
Dr. Luis Alejandro Jaramillo, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14050 Town Loop Blvd, Suite 204, Orlando, FL 32837 Phone: 407-251-8800 | |
Dr. Angelo Alberto Leto Barone, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6535 Nemours Pkwy, Orlando, FL 32827 Phone: 407-567-4000 Fax: 407-567-5924 | |
Dr. Jerry Alan Rubin, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6900 Turkey Lake Rd, Suite 1-7, Orlando, FL 32819 Phone: 321-939-3300 Fax: 321-939-3303 | |
Dr. Florencio Jorge Gonzalez, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3100 Clay Ave, Suite # 299, Orlando, FL 32804 Phone: 407-447-1628 | |
Dr. Omar E Beidas, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 265 E Rollins St Ste 5300, Orlando, FL 32804 Phone: 407-821-3555 Fax: 407-821-3556 |